Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Recently, ViiV Healthcare applied for approval of the first long-acting injectable HIV regimen.
This $14 million research project aims to find out. Here’s why it’s based in Miami.
The Mosaico study will enroll gay and bisexual men and transgender people at significant risk for the virus.
Investigators led by Scripps Research will study vaccines that coax the immune system into creating antibodies that protect against HIV.
Funding bills in the House prioritize Ryan White efforts, the Office of AIDS Research, opioid programs and more.
“It’s hard to be proud when your health is on the line and when stigma is beating you up,” said AIDS United’s Jesse Milan.
The NIH-funded research focuses on chronic conditions other than HIV and examines gender differences.
In a win for abortion opponents, the Trump administration limits funding of research using fetal tissue.
Federal researchers describe two paths to a vaccine—and one of them uses high-tech computers to design a vaccine candidate!
The trial will investigate whether injections of long-acting cabotegravir and rilpivirine yield a superior rate of viral suppression.
A $3.5 million grant to the University of Illinois at Chicago will help researchers find out.
Plus: Once again federal funds get diverted from health care and into the detention of immigrant youth.
This may help explain why HIV-positive individuals have a harder time quitting cigarettes than those who don’t have the virus.
The director of the National Institutes of Health (NIH) supports the U=U message.
National Institutes of Health (NIH) officials discuss scientific evidence and principles underlying the U=U concept.
The new federal initiative will work with existing research programs in eight cities.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.